ESC 365
Menu
Home
Search
Events
About
ESC Platforms
Escardio.org
ESC 365
ESC eLearning
Create an account
Sign in
Back
Open Access
Icosapent Ethyl, a new player in reducing atherothrombotic risk?
Session:
One step further in reducing established cardiovascular disease risk: targeting atherothrombosis after REDUCE-IT
Topic:
Thrombosis, Bleeding
Speaker:
Professor V. Aboyans (Limoges, FR)
Event:
EuroThrombosis and EuroVessels 2022
Seminar Presentation
About the speaker
Professor Victor Aboyans
University Hospital of Limoges, Limoges (France)
21
presentations
5
followers
1
more
presentation
in this session
Established CVD and atherothrombosis: how did we get here and how can we get out
Speaker:
Doctor F. Araujo (Lisbon, PT)
Access
Access the full session
One step further in reducing established cardiovascular disease risk: targeting atherothrombosis after REDUCE-IT
Speakers:
Professor V. Aboyans, Doctor F. Araujo
Access
About the event
EuroThrombosis and EuroVessels 2022
20 October - 22 October 2022
Access
ESC 365 is supported by